Chapter 8

Application of next-generation sequencing in haematology

Angela Hamblin

Angela Hamblin

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, Oxford University, Oxford, United Kingdom

Search for more papers by this author
Adele Timbs

Adele Timbs

Oxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Search for more papers by this author
First published: 04 April 2025

Summary

For over 60 years since the discovery of the Philadelphia chromosome, the role of genomics in haematological diseases has been evident. With the advent of Next- Generation Sequencing (NGS), which allows large regions of multiple individuals’ genomes to be analysed simultaneously, the option of undertaking more comprehensive genomic testing in both malignant and non-malignant haematological disorders has become both practical and affordable. The chapter ‘Application of Next- Generation Sequencing in Haematology’ explores the available sequencing assays, required bioinformatics and variant interpretation as well as the clinical utility and practical considerations of this new technology.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.